These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 7964602

  • 1. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S, Tsutsumi R, Burke A, Carlson G, Porro V, Seko Y, Okumura K, Kawana R, Virmani R.
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [Abstract] [Full Text] [Related]

  • 2. Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection.
    Andréoletti L, Hober D, Becquart P, Belaich S, Copin MC, Lambert V, Wattré P.
    J Med Virol; 1997 Jun; 52(2):206-14. PubMed ID: 9179770
    [Abstract] [Full Text] [Related]

  • 3. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
    Hober D, Andreoletti L, Shen L, Copin MC, Desmidt A, Wattré P.
    Microbiol Immunol; 1996 Jun; 40(11):837-45. PubMed ID: 8985939
    [Abstract] [Full Text] [Related]

  • 4. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
    Glück B, Schmidtke M, Merkle I, Stelzner A, Gemsa D.
    J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
    [Abstract] [Full Text] [Related]

  • 5. Intracellular viral localization in murine coxsackievirus-B3 myocarditis. Ultrastructural study by electron microscopic in situ hybridization.
    Ukimura A, Deguchi H, Kitaura Y, Fujioka S, Hirasawa M, Kawamura K, Hirai K.
    Am J Pathol; 1997 Jun; 150(6):2061-74. PubMed ID: 9176398
    [Abstract] [Full Text] [Related]

  • 6. Myocardial injury occurs earlier than myocardial inflammation in acute experimental viral myocarditis.
    Lim BK, Shin JO, Choe SC, Choi SW, Jeong JO, Seong IW, Kim DK, Jeon ES.
    Exp Mol Med; 2005 Feb 28; 37(1):51-7. PubMed ID: 15761252
    [Abstract] [Full Text] [Related]

  • 7. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M, Merkle I, Klingel K, Hammerschmidt E, Zautner AE, Wutzler P.
    J Med Virol; 2007 Sep 28; 79(9):1334-42. PubMed ID: 17607777
    [Abstract] [Full Text] [Related]

  • 8. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
    Schmidtke M, Glück B, Merkle I, Hofmann P, Stelzner A, Gemsa D.
    J Med Virol; 2000 Aug 28; 61(4):518-26. PubMed ID: 10897072
    [Abstract] [Full Text] [Related]

  • 9. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
    Merkle I, Tonew M, Glück B, Schmidtke M, Egerer R, Stelzner A.
    J Hum Virol; 1999 Aug 28; 2(6):369-79. PubMed ID: 10774554
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
    Chang H, Han B, Han XZ.
    Zhonghua Er Ke Za Zhi; 2005 Dec 28; 43(12):920-4. PubMed ID: 16412356
    [Abstract] [Full Text] [Related]

  • 15. Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.
    Zhao T, Wu X, Song D, Fang M, Guo S, Zhang P, Wang L, Wang L, Yu Y.
    Int Immunopharmacol; 2012 Dec 28; 14(4):665-73. PubMed ID: 23063973
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice.
    Schnurr DP, Cao Y, Schmidt NJ.
    J Gen Virol; 1984 Jul 28; 65 ( Pt 7)():1197-201. PubMed ID: 6747601
    [Abstract] [Full Text] [Related]

  • 19. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
    Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S.
    J Virol; 1996 Nov 28; 70(11):7811-8. PubMed ID: 8892902
    [Abstract] [Full Text] [Related]

  • 20. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
    Qian H, Liu L.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May 28; 30(5):509-12. PubMed ID: 24796747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.